China Supplier Fujimycin - Capecitabine CAS 154361-50-9 Purity 98.0%~102.0% API High Quality – Ruifu

Short Description:

Product Detail

Product Tags

Feedback (2)

Our team through qualified training. Skilled professional knowledge, powerful sense of support, to satisfy the support desires of consumers for 475207-59-1, 83150-76-9, Molecular weight 293.31, We have a big inventory to fulfill our customer's demands and needs.

China Supplier Fujimycin - Capecitabine CAS 154361-50-9 Purity 98.0%~102.0% API High Quality – Ruifu Detail:

Manufacturer with High Purity and Stable Quality
Commercial Supply Capecitabine (CAS: 154361-50-9) Related Intermediates:
Capecitabine CAS: 154361-50-9
1,2,3-Triacetyl-5-deoxy-D-ribose CAS: 62211-93-2
2′,3′-Di-O-acetyl-5′-deoxy-5-fluorocytidine CAS: 161599-46-8

Chemical Name	Capecitabine
CAS Number	154361-50-9
CAT Number	RF-API08
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C15H22FN3O6
Molecular Weight	359.35
Brand	Ruifu Chemical

Item	Specifications
Appearance	White Powder
Identification	IR Spectrum Conform to the Standard
Identification	HPLC Conform to the Standard
Purity	98.0%~102.0%
Impurity A	≤0.30%
Impurity B	≤0.30%
Impurity C	≤0.30%
Single Unspecified Impurity	≤0.10%
Total Unspecified Impurities	≤0.50%
Total Impurities	≤1.5%
Moisture (K.F)	≤0.30%
Heavy Metals	≤10ppm
Residue on ignition	≤0.10%
Test Standard	Enterprise Standard
Usage	Capecitabine CAS: 154361-50-9 is widely used in metastatic breast cancer

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Capecitabine is a new form of oral fluorinated pyrimidine drug. Capecitabine was developed by Roche Pharmaceuticals, and its commercial name is Xeloda. Capecitabine can change in vivo into 5- FU, an anti-metabolizim fluorine pyrimidine deoxynucleoside carbamate drug that targets cancer cells to inhibit cell division and disrupt RNA and protein synthesis. Its effects are significantly tied to the level of TP enzyme expression in neoplastic tissue and to DPD enzyme in vivo expression. It is suitable as further treatment for advanced primary or metastatic breast cancer patients who have not responded to paclitaxel or anthracycline antibiotics. As an anticancer drug, it is mostly used to treat advanced primary or metastatic breast cancer, as well as in treatment for non-small cell lung cancer, pancreatic cancer, bladder cancer, rectal cancer, colon cancer, gastric cancer, and other solid tumors. Many drugs such as taxanes (paclitaxel, docetaxel, mitomycin, cisplatin, etc.) can increase TP enzyme expression in neoplastic tissues and also have curative effects on gastric cancer. When used in combination with Capecitabine, these drugs can also improve Capecitabine’s anticancer abilities and produce synergistic effects.

Product detail pictures:

Related Product Guide:

Which has a positive and progressive attitude to customer's desire, our corporation constantly improves our merchandise quality to satisfy the desires of consumers and further focuses on safety, reliability, environmental demands, and innovation of China Supplier Fujimycin - Capecitabine CAS 154361-50-9 Purity 98.0%~102.0% API High Quality – Ruifu , The product will supply to all over the world, such as: Poland, Norway, moldova, We would very much welcome an opportunity to do business with you and have pleasure in attaching further details of our products. Excellent quality, competitive prices,punctual delivery and dependable service can be guaranteed.